After strategic adjustment, TaiMei Medical Technology has achieved remarkable results in improving quality and efficiency. It has proactively optimized its revenue structure, with core operational indicators improving, newly signed orders growing at an accelerated pace, and profitability enhancing. The large-scale implementation of the AI strategy has become the core driving force for performance growth, establishing TaiMei as a leader in the field of AI + new drug clinical development.
